Vanda Pharmaceuticals  logo
Vanda Pharmaceuticals VNDA
€ 4.87 3.14%

Quartalsbericht 2024-Q3
hinzugefügt 07.11.2024

report update icon

Vanda Pharmaceuticals Kennzahlen 2011-2024 | VNDA

Kennzahlen Jährlich Vanda Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

92.9 65.8 26.3 30.6 6.0 56.9 -46.6 -32.1 -9.0 19.2 -19.6 -4.4 -14.1

P/S

1.2 1.6 3.2 2.9 3.0 7.4 4.4 4.0 3.3 7.7 11.7 3.7 4.4

EPS

0.0 0.1 0.6 0.4 2.2 0.5 -0.3 -0.4 -0.9 0.6 -0.7 -1.0 -0.3

EV (Enterprise Value)

201 M 385 M 908 M 734 M 719 M 1.43 B 765 M 616 M 390 M 337 M 431 M 159 M 200 M

EBITDA per Share

-0.23 0.13 0.78 0.53 0.458 0.457 -0.339 -0.176 -0.644 -1.59 -0.623 -0.947 -0.328

EV/EBITDA

20.0 26.1 26.6 59.0 -45.6 -70.4 -11.4 -5.9 -17.5 -1.3 -5.5

PEG

-1.56 -1.29 -1.66 -0.77 0.02 0.23 -3.18 -0.57 0.03 0.1 -0.62 0.02 0.06

P/B

0.4 0.8 1.7 1.6 1.7 5.2 5.5 4.4 2.7 2.4 9.0 12.4 4.1

P/CF

18.2 12.9 13.6 13.8 15.4 310.6 -198.7 -60.8 36.3 -4.3 -10.0 -2.6 -4.8

ROE %

0.46 1.19 6.57 5.15 28.12 9.15 -11.85 -13.71 -29.97 12.55 -45.90 -279.29 -29.28

ROA %

0.39 0.99 5.58 4.37 23.89 7.59 -7.58 -8.56 -18.71 11.76 -14.13 -20.42 -5.37

ROCE %

-2.56 1.20 8.35 6.01 5.38 7.79 -12.51 -11.60 -24.85 -35.11 -18.46 -27.35 -7.09

Current Ratio

6.3 5.9 6.7 6.7 6.0 5.6 2.4 3.5 3.2 18.2 4.1 3.9 4.9

DSO

64.1 47.3 42.5 41.5 42.4 54.4 38.9 50.7 54.2 26.6 23.3 16.1 18.9

DIO

31.5 16.7 16.4 18.9 17.0 17.7 17.2 11.5 20.1 1134.0 - 161.3 -

DPO

- - - - - - 415.9 239.2 245.3 192.5 - 812.1 -

Betriebszyklus

95.6 64.0 58.9 60.4 59.4 72.1 56.1 62.2 74.4 1160.6 - 177.4 -

Finanzkreislauf

95.6 64.0 58.9 60.4 59.4 72.1 -359.8 -177.0 -170.9 968.0 - -634.7 -

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich Vanda Pharmaceuticals

2024-Q3 2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.09 -0.08 - - 0.03 0.06 - 0.06 0.05 -0.11 - 0.14 0.17 0.16 0.15 0.11 0.16 0.01 0.08 1.88 0.22 -0.01 0.2 0.14 0.09 0.07 -0.04 -0.1 -0.03 -0.17 -0.01 -0.01 -0.11 -0.29 -0.35 -0.22 -0.13 -0.24 1.85 -0.04 -0.64 -0.79 -0.23 -0.17 -0.11 -0.15 -0.23 -0.19 -0.28 -0.28 -0.2 -0.11 -0.05 -

EBITDA per Share

-0.16 -0.14 - -0.1 -0.04 0.04 - 0.08 0.07 -0.13 - 0.21 0.23 0.19 0.19 0.16 0.18 - 0.08 0.22 0.2 -0.03 0.17 0.14 0.09 0.06 -0.05 -0.09 -0.03 -0.17 -0.01 - -0.1 -0.28 -0.35 -0.21 -0.12 -0.24 1.68 -0.03 -0.63 -0.79 -0.23 -0.16 -0.11 -0.16 -0.23 -0.17 -0.27 -0.28 -0.21 -0.11 -0.05 -

ROE %

-1.77 -0.50 0.91 1.55 2.16 2.38 -0.14 1.43 2.38 3.88 5.43 7.24 6.97 6.89 5.15 4.37 27.49 28.37 28.12 30.85 9.02 7.89 9.15 3.99 -2.07 -4.92 -11.85 -10.91 -7.77 -10.12 -13.71 -24.38 -31.16 -31.69 -29.97 24.51 30.73 21.37 12.55 -48.36 -59.72 -53.98 -47.72 -94.46 -135.98 -209.15 -279.29 -231.49 -186.90 -110.07 -29.28 -9.18 -4.01 0.41

ROA %

-1.48 -0.41 0.76 1.29 1.79 0.49 -1.60 -0.26 1.62 3.32 4.63 6.17 5.94 5.88 4.37 3.71 23.36 24.10 23.89 26.13 7.53 6.54 7.59 3.58 -0.80 -2.93 -7.58 -6.97 -4.96 -6.41 -8.56 -15.22 -19.46 -19.79 -18.71 28.84 32.45 22.41 11.76 -34.25 -37.19 -26.99 -14.69 -13.99 -14.15 -17.70 -20.42 -18.75 -16.50 -11.32 -5.37 -1.68 -0.73 0.07

ROCE %

-6.11 -4.61 -1.26 -0.50 1.36 2.57 -0.09 2.10 3.54 5.43 6.97 9.28 8.80 8.25 6.01 4.74 5.65 6.03 5.55 7.84 7.49 6.50 7.89 2.93 -3.08 -5.96 -12.87 -11.73 -8.48 -10.66 -14.14 -24.84 -31.51 -31.97 -30.21 24.32 30.60 21.26 12.47 -48.52 -59.93 -54.23 -48.05 -95.29 -137.44 -211.34 -284.96 -237.71 -193.08 -115.97 -31.99 -9.84 -4.52 0.02

Current Ratio

6.2 6.0 6.3 6.5 6.3 5.9 5.9 5.9 - 6.0 6.7 6.7 6.6 7.2 6.7 6.7 6.7 6.7 6.6 6.6 6.6 6.6 5.9 5.9 5.9 5.9 2.8 2.8 2.8 2.8 2.7 2.7 2.7 2.7 2.7 2.7 2.7 2.7 15.8 15.8 15.8 15.8 1.4 1.4 1.4 1.4 1.1 1.1 1.1 1.1 1.2 1.2 1.2 1.2

DSO

81.0 68.7 - 73.9 57.6 42.4 - 20.5 21.6 47.7 - 51.1 46.1 44.8 40.5 45.5 44.1 44.4 39.5 40.5 40.7 52.7 49.5 53.5 55.5 48.5 36.3 38.9 38.2 46.2 48.4 48.1 51.3 50.2 46.8 52.6 54.0 41.2 21.7 22.6 30.7 28.4 21.1 21.3 22.3 18.1 13.5 12.9 12.7 15.6 17.6 18.5 19.9 -

DIO

55.1 47.2 - 31.1 28.5 22.0 - 11.5 9.7 18.6 - 13.1 16.8 20.0 - 19.8 20.0 21.2 - 15.3 16.3 19.0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

136.2 115.9 - 105.0 86.1 64.3 - 32.0 31.3 66.4 - 64.3 62.9 64.8 40.5 65.2 64.0 65.6 39.5 55.8 57.1 71.8 49.5 53.5 55.5 48.5 36.3 38.9 38.2 46.2 48.4 48.1 51.3 50.2 46.8 52.6 54.0 41.2 21.7 22.6 30.7 28.4 21.1 21.3 22.3 18.1 13.5 12.9 12.7 15.6 17.6 18.5 19.9 -

Finanzkreislauf

136.2 115.9 - 105.0 86.1 64.3 - 32.0 31.3 66.4 - 64.3 62.9 64.8 40.5 65.2 64.0 65.6 39.5 55.8 57.1 71.8 49.5 53.5 55.5 48.5 36.3 38.9 38.2 46.2 48.4 48.1 51.3 50.2 46.8 52.6 54.0 41.2 21.7 22.6 30.7 28.4 21.1 21.3 22.3 18.1 13.5 12.9 12.7 15.6 17.6 18.5 19.9 -

Alle Zahlen in USD-Währung